Last quarter (Q4 2022), Abingdon Health PLC's total revenue was £―, a decrease of ― from the same quarter last year. In Q4, Abingdon Health PLC's net income was £―. See Abingdon Health PLC’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 23	Jun 22	Jun 21	Jun 20	Jun 19
Total Revenue	-	£ 4.04M	£ 3.08M	£ 11.77M	£ 5.24M	£ 2.28M
Cost of Revenue	-	£ 1.97M	£ 6.43M	£ 7.47M	£ 1.15M	£ 705.38K
Gross Profit	-	£ 2.08M	£ -3.35M	£ 4.29M	£ 4.09M	£ 1.57M
Operating Expense	-	£ 5.62M	£ 4.36M	£ 16.37M	£ 3.87M	£ 2.97M
Operating Income	-	£ -3.54M	£ -7.71M	£ -12.08M	£ 217.00K	£ -1.40M
Net Non Operating Interest Income Expense	-	£ -72.00K	£ -65.00K	£ -234.00K	£ -63.00K	£ -18.95K
Other Income Expense	-	£ -255.00K	£ 4.16M	£ 1.60M	-	-
Pretax Income	-	£ -3.56M	£ -21.59M	£ -14.36M	£ -3.38M	£ -1.41M
Tax Provision	-	£ -105.00K	£ -331.00K	£ 19.00K	£ -1.00K	£ -154.31K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	£ -3.45M	£ -21.26M	£ -14.38M	£ -3.37M	£ -1.26M
Basic EPS	-	£ -0.01	£ -0.07	£ -0.03	£ -0.04	£ -0.01
Diluted EPS	-	£ -0.01	£ -0.07	£ -0.03	£ -0.04	£ -0.01
Basic Average Shares	-	£ 304.03M	£ 583.25M	£ 525.85M	£ 245.90M	£ 95.70M
Diluted Average Shares	-	£ 305.82M	-	£ 262.93M	£ 251.09M	£ 95.70M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	£ <0.01	-
Reported Normalized Diluted E P S	-	-	-	-	£ <0.01	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	-	£ 7.59M	-	-	£ 5.02M	£ 3.67M
Net Income From Continuing And Discontinued Operation	-	£ -3.45M	£ -21.26M	£ -14.38M	£ -3.37M	£ -1.26M
Normalized Income	-	£ -3.38M	£ -12.26M	£ -11.18M	£ 153.95K	£ -1.26M
Interest Expense	-	-	-	-	£ 65.00K	£ 22.43K
EBIT	-	£ -3.48M	£ -21.52M	£ -14.12M	£ -3.31M	£ -1.39M
EBITDA	-	£ -2.73M	£ -12.70M	£ -13.38M	£ 810.00K	£ -1.10M

Currency in GBP

Abingdon Health PLC Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing